Business Development

Technology Transfer

Technology Transfer is a procedure enabling the receiver site to produce a product in compliance with the documents notified to the authorities in the same or e better quality compared to the donor site. This requires a content-related support by the donor site as well as the provision of all technical and product-related documents. CinnaGen has a valuable experience on this issue as both licensees and licensor. As it has been distinctive throughout our history, our TT Department has always been seeking new co-operation and our expert team would welcome any opportunities for new projects.


Export is regarded as the most accelerating way of developing into a highly profitable new phase of growth. Here is the point which the entire endeavours and plans of all Business Development Departments, would be put into practice.

Export Department offers the prospect of present markets, more sales, better profits and a greater spread of customers. Without a clear strategy, however, none of these benefits are likely to be realised.

Since international trade is often more risky and costly than doing business at home, once you do start to win orders, you would encounter legal, financial and logistical challenges, particularly as you might be working in diverse languages and currencies. Hence, we have defined our major framework to move through ; a disciplined, professional, well-structured approach from the initial point.

Our Export department has been based on well-educated staff who are the most skillful, educated and dedicated ones in their own field.

Our Export team members are fully prepared to:

  • assess our customer’s position.
  • draw up an action plan.
  • research potential markets and monitoring the maintenance of the current markets.
  • check the legal status and tax position of the export procedures.
  • use a mix of policies including, fiscal incentives, institutional changes, enhanced market access across the world and periodic update reports of export markets in order to monitor our global export status instantly.

The core of the Export Department’s strategy is to retain presence and market share in our old developed country markets, rocket the value chain in providing products in these markets and unlock new vistas, both in terms of markets and new products in the new markets. Focus on markets in Asia (including ASEAN), Africa and Latin America to strengthen our presence in newly opened up markets.

Market Development

Market Development and Partnering: At CinnaGen we employ modern technologies to manufacture high quality lifesaving medicines. In addition, finding and accessing new markets and new molecules remains one of the most pivotal aspect of our business.

CinnaGen’s Market Development goal is to extend the presence of CinnaGen’s products beyond our geographical borders. The affordability of cost-effective medicines for patients around the world, helping countries to optimize the health care expenditures and a quality-based competition has made CinnaGen the biggest exporter of biotech products in Iran and the middle-east.  We believe in open and honest collaborations which can create mutual value.

The partnering process:

The partnering process starts with locating areas where our medicines could bring a change to make life better for patients. Market Development team of CinnaGen consists of professionally trained individuals with a cross-functional and diverse qualifications who will help you throughout the partnering process. We welcome all business and scientific proposals from Academia and/or strategic partners with whom we can augment and complete our strengths. We diligently and transparently evaluate the project with you and we ensure that your opportunity receives a prompt comprehensive evaluation.

As of now, our team members have been dedicated to deliver excellent quality service to our clients worldwide by providing patients with better access to high-quality and cost-effective medicines and this will continue to remain our main commitment.

Our areas of interest include: Biosimilars, peptide-based therapeutics, Therapeutic enzymes, Monoclonal Antibodies and Recombinant proteins.

Business Models at CinnaGen:

  • Out-licensing
  • In-licensing
  • Supply and Distribution (API and Finished Product)
  • Agency
  • Technology Transfer
  • R&D Partnering (Research Collaboration and  Co-Development)
  • Joint-Venture
  • Contract Manufacturing
  • Acquisitions and Investment

For more information about Business Development Opportunities please contact : or click the following link:

Mail To CinnaGen Business Development

Jan2018 / Public Relations Department /